NYSE · US Equities - Quant Strat · USA
The companies inside CBLS trade 31% above what we estimate they are worth. We could give a verdict on 60% of the fund's weight: 68 holdings as reported to the SEC at 31 Jul 2026.
Where the money is: 6% in companies in the buy zone, 8% about fairly valued, 47% overvalued, 40% without a verdict.
The ten largest holdings, with our verdict on each:
Its expense ratio is 1.89% a year: on $10,000 held flat that is $1,890 over 10 years and $3,780 over 20.